Page last updated: 2024-09-03

l 692429 and thyroxine

l 692429 has been researched along with thyroxine in 2 studies

Compound Research Comparison

Studies (l 692429)	Trials (l 692429)	Recent Studies (post-2010) (l 692429)	Studies (thyroxine)	Trials (thyroxine)	Recent Studies (post-2010) (thyroxine)
40	5	1	38,989	1,410	6,550

Protein Interaction Comparison

Protein	Taxonomy	thyroxine (IC50)
Transthyretin	Homo sapiens (human)	2.1939
UDP-glucuronosyltransferase 1A1	Homo sapiens (human)	5.25
Solute carrier organic anion transporter family member 4C1	Homo sapiens (human)	8
Bile acid receptor	Homo sapiens (human)	7.86

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barakat, KJ; Butler, B; Chan, WW; Chen, MH; Cheng, K; Hickey, G; Johnston, DB; Nargund, RP; Patchett, AA; Tata, JR	1
Clark, J; Cunningham, P; Hickey, G; Jacks, T; Judith, F; Krupa, D; Schoen, WR; Smith, RG; Taylor, J	1

Other Studies

2 other study(ies) available for l 692429 and thyroxine

Article	Year
Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue. Proceedings of the National Academy of Sciences of the United States of America, 1995, Jul-18, Volume: 92, Issue:15 Topics: Administration, Oral; Aldosterone; Amino Acid Sequence; Animals; Benzazepines; Cells, Cultured; Dogs; Drug Design; Drug Synergism; Growth Hormone; Indoles; Injections, Intravenous; Luteinizing Hormone; Male; Molecular Sequence Data; Oligopeptides; Pituitary Gland; Prolactin; Rats; Spiro Compounds; Structure-Activity Relationship; Tetrazoles; Thyroxine	1995
Efficacy and specificity of L-692,429, a novel nonpeptidyl growth hormone secretagogue, in beagles. Endocrinology, 1994, Volume: 134, Issue:2 Topics: Adrenocorticotropic Hormone; Aldosterone; Animals; Benzazepines; Dogs; Female; Growth Hormone; Hydrocortisone; Injections, Intravenous; Insulin; Kinetics; Luteinizing Hormone; Male; Prolactin; Tetrazoles; Thyroxine; Time Factors; Triiodothyronine	1994

Article

Year

Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue.

Proceedings of the National Academy of Sciences of the United States of America, 1995, Jul-18, Volume: 92, Issue:15

Topics: Administration, Oral; Aldosterone; Amino Acid Sequence; Animals; Benzazepines; Cells, Cultured; Dogs; Drug Design; Drug Synergism; Growth Hormone; Indoles; Injections, Intravenous; Luteinizing Hormone; Male; Molecular Sequence Data; Oligopeptides; Pituitary Gland; Prolactin; Rats; Spiro Compounds; Structure-Activity Relationship; Tetrazoles; Thyroxine

1995

Efficacy and specificity of L-692,429, a novel nonpeptidyl growth hormone secretagogue, in beagles.

Endocrinology, 1994, Volume: 134, Issue:2

Topics: Adrenocorticotropic Hormone; Aldosterone; Animals; Benzazepines; Dogs; Female; Growth Hormone; Hydrocortisone; Injections, Intravenous; Insulin; Kinetics; Luteinizing Hormone; Male; Prolactin; Tetrazoles; Thyroxine; Time Factors; Triiodothyronine

1994